In a new deep analysis of high-grade serous ovarian cancer (HGSOC), researchers have identified a common pathway that could provide a target for new drugs.
Dr. Alexander Melamed, a member of the Cancer Population Science program at the HICCC, joined Columbia in July of 2019 as assistant professor of obstetrics and gynecology at Columbia’s VP&S.